Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

Bonnet MM Pinoges LL Varaine FF Oberhauser BB O'Brien DD Kebede YY Hewison CC Zachariah RR Ferradini LL
AIDS (London, England) 2006 Jun 12; 20(9); 1275-9. doi: 10.1097/01.aids.0000232235.26630.ee. Epub 2006 10 04

Abstract

BACKGROUND: HAART reduces tuberculosis (TB) incidence in people living with HIV/AIDS but those starting HAART may develop active TB or subclinical TB may become apparent in the immune reconstitution inflammatory syndrome.

OBJECTIVE: To measure the incidence rate of notified TB in people receiving HAART in five HIV programmes occurring in low-resource countries with a high TB/HIV burden.

METHODS: A retrospective review in five Médecins Sans Frontières programmes (Cambodia, Thailand, Kenya, Malawi and Cameroon) allowed incidence rates of notified TB to be calculated based on follow-up time after HAART initiation.

RESULT: Among 3151 patients analysed, 90% had a CD4 cell count of

CONCLUSION: High incidence rates of notified TB under HAART in programmes held in poor-resource countries were observed; these were likely to include both undiagnosed prevalent TB at HAART initiation and subclinical TB developing during the immune reconstitution inflammatory syndrome. This raises operational issues concerning TB diagnosis and treatment of TB/HIV-coinfected patients and prompts for urgent TB and HIV care integration.